Work

Folfirinox versus gemcitabine/nab-paclitaxel for neoadjuvant treatment of resectable and borderline resectable pancreatic adenocarcinoma: A propensity matched analysis.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.4_suppl.402

Authors: Mashaal Dhir, Mazen S Zenati, Ahmad Hamad, Aatur D. Singhi, Nathan Bahary, Melissa Ellen Hogg, Herbert Zeh, Amer H. Zureikat

Institutions: SUNY Upstate Medical University, University of Pittsburgh Medical Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2802954645

Cites:

Cited by: 1

Related to: 10